ImmuMetrix
Company

Last deal

$6.38M

Amount

Private Equity

Stage

10.04.2013

Date

1

all rounds

$6.38M

Total amount

date founded

Financing round

General

About Company
ImmuMetrix is a biotech company that develops immune profiles for gene therapy treatments.

Industry

Sector :

Subsector :

Also Known As

ImmuMetrix Inc.

founded date

01.01.2010

Company Type

For Profit

Last funding type

Private Equity

IPO status

Private

Description

Based in Palo Alto, California, ImmuMetrix was founded in 2010 and specializes in transplant diagnostics. In addition to its diagnostic services, the company has developed immune profiles that can be used in the treatment of gene carried diseases. These profiles provide valuable insights into the immune system, allowing for more targeted and effective treatments. ImmuMetrix is committed to advancing the field of gene therapy and improving patient outcomes through its innovative technologies.
Contacts
Similar Companies
1000
Yuce Biological Technology

Yuce Biological Technology

Yuce Biological Technology is a biotech company specializing in cancer diagnosis through gene detection.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Financial Services

Location

Shenzhen, Guangdong Province, China

total rounds

4

total raised

$48.73M

count Of Investments

1
TransMolecular

TransMolecular

TransMolecular Inc is a biotech company that focuses on treating cancer and pain.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Birmingham, AL, USA

total rounds

3

total raised

$42.2M
TikoMed

TikoMed

TikoMed is a biotechnology company that develops and commercializes innovative treatments for severe and life-threatening conditions.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

263 61 Viken, Sweden

total rounds

2

total raised

$14.63M
Exuma Biotech

Exuma Biotech

EXUMA Biotech develops Chimeric Antigen Receptor (CAR)-T cell products for solid tumors.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Grand Cayman, Cayman Islands

total rounds

4

total raised

$107M
M&A Details
1

Transaction name

Acquired by

CareDx

announced date

27.05.2014

Financials

Funding Rounds
1
1

Number of Funding Rounds

$6.38M

Money Raised

Their latest funding was raised on 10.04.2013. Their latest round Private Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
10.04.2013
$6.38M
Co-Investors

People

Employee Profiles
1

Stephen Quake

Founder

Activity

Recent News
0